These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36413128)

  • 1. χ-Separation Imaging for Diagnosis of Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder.
    Kim W; Shin HG; Lee H; Park D; Kang J; Nam Y; Lee J; Jang J
    Radiology; 2023 Apr; 307(1):e220941. PubMed ID: 36413128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Jeong IH; Choi JY; Kim SH; Hyun JW; Joung A; Lee J; Kim HJ
    Mult Scler; 2016 Oct; 22(12):1616-1620. PubMed ID: 26920375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis.
    Cai MT; Zhang YX; Zheng Y; Fang W; Ding MP
    Mult Scler Relat Disord; 2019 Jul; 32():41-45. PubMed ID: 31030018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
    Liao MF; Chang KH; Lyu RK; Huang CC; Chang HS; Wu YR; Chen CM; Chu CC; Kuo HC; Ro LS
    BMC Neurol; 2014 Nov; 14():218. PubMed ID: 25433369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Liu Y; Dong D; Zhang L; Zang Y; Duan Y; Qiu X; Huang J; Dong H; Barkhof F; Hu C; Fang M; Tian J; Li K
    Eur Radiol; 2019 Sep; 29(9):4670-4677. PubMed ID: 30770971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating multiple sclerosis and neuromyelitis optica spectrum disorders through pontine trigeminal nerve lesions: A comparative MRI study.
    Kojita Y; Kono AK; Yamada T; Yamada M; Im SW; Kozuka T; Kaida H; Kuwahara M; Nagai Y; Ishii K
    Eur J Radiol; 2024 Sep; 178():111597. PubMed ID: 38996736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
    Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
    Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis.
    Hyun JW; Huh SY; Shin HJ; Woodhall M; Kim SH; Irani SR; Lee SH; Waters P; Kim HJ
    Mult Scler; 2019 Apr; 25(4):585-590. PubMed ID: 29512413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility-weighted image features in AQP4-negative-NMOSD versus MS.
    Gao C; Su L; Li H; Song T; Liu Y; Duan Y; Shi FD
    Mult Scler Relat Disord; 2024 Feb; 82():105406. PubMed ID: 38176283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between R2'-based and R2*-based χ-separation methods: A clinical evaluation in individuals with multiple sclerosis.
    Ji S; Jang J; Kim M; Lee H; Kim W; Lee J; Shin HG
    NMR Biomed; 2024 Sep; 37(9):e5167. PubMed ID: 38697612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.
    Cortese R; Magnollay L; Tur C; Abdel-Aziz K; Jacob A; De Angelis F; Yiannakas MC; Prados F; Ourselin S; Yousry TA; Barkhof F; Ciccarelli O
    Neurology; 2018 Apr; 90(14):e1183-e1190. PubMed ID: 29514948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder.
    Combes AJE; Matthews L; Lee JS; Li DKB; Carruthers R; Traboulsee AL; Barker GJ; Palace J; Kolind S
    Neuroimage Clin; 2017; 16():17-22. PubMed ID: 28725551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
    Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
    Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.
    Ciotti JR; Eby NS; Brier MR; Wu GF; Chahin S; Cross AH; Naismith RT
    Mult Scler; 2022 Jan; 28(1):49-60. PubMed ID: 33870786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Masuda H; Mori M; Uzawa A; Uchida T; Ohtani R; Kuwabara S
    PLoS One; 2020; 15(4):e0224419. PubMed ID: 32251416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model.
    Seok JM; Cho W; Chung YH; Ju H; Kim ST; Seong JK; Min JH
    Sci Rep; 2023 Jul; 13(1):11625. PubMed ID: 37468553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
    Sinnecker T; Clarke MA; Meier D; Enzinger C; Calabrese M; De Stefano N; Pitiot A; Giorgio A; Schoonheim MM; Paul F; Pawlak MA; Schmidt R; Kappos L; Montalban X; Rovira À; Evangelou N; Wuerfel J;
    JAMA Neurol; 2019 Dec; 76(12):1446-1456. PubMed ID: 31424490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.